pyridostigmine bromide has been researched along with Insulin Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, YL; Li, DL; Wu, Q; Xu, M; Xue, RQ; Yang, S; Yu, XJ; Zang, WJ; Zhao, M | 1 |
| Andersen, M; Flyvbjerg, A; Frystyk, J; Glintborg, D; Hagen, C; Hermann, AP; Støving, RK; Veldhuis, JD | 1 |
1 trial(s) available for pyridostigmine bromide and Insulin Resistance
| Article | Year |
|---|---|
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome.
Topics: Absorptiometry, Photon; Adult; Area Under Curve; Body Composition; Cholinesterase Inhibitors; Double-Blind Method; Female; Gonadal Steroid Hormones; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Menstruation; Pioglitazone; Polycystic Ovary Syndrome; PPAR gamma; Pyridostigmine Bromide; Stimulation, Chemical; Thiazolidinediones | 2005 |
1 other study(ies) available for pyridostigmine bromide and Insulin Resistance
| Article | Year |
|---|---|
Pyridostigmine alleviates cardiac dysfunction via improving mitochondrial cristae shape in a mouse model of metabolic syndrome.
Topics: Animals; Cholinesterase Inhibitors; Diet, High-Fat; Disease Models, Animal; Heart Diseases; Insulin Resistance; Male; Metabolic Syndrome; Mice; Mitochondria, Heart; Mitochondrial Membranes; Mitochondrial Proteins; Organelle Shape; Pyridostigmine Bromide | 2019 |